Frequently Asked Questions:
The global automatic veterinary biochemistry analyzer market was valued at USD 15.2 Billion in 2022.
The automatic veterinary biochemistry analyzer market is expected to grow at a CAGR of 4.50% between 2023 and 2030, reaching USD 20.7 Billion in 2030.
Bench-top veterinary biochemistry analyzer is the leading segment by type, holding over 43% share in terms of value in 2022.
The pet hospital segment governs the demand for automatic veterinary biochemistry analyzers in the world, holding a massive share of over 80% in 2022.
The other segment is expected to post the highest CAGR during the forecast period.
North America is fueling the growth of the automatic veterinary biochemistry analyzer industry, with an over one-third share in 2022.
The top players include Ravensburger, Buffalo Games, Disney, Piatnik, and Hape. Other major players include Biochemical Systems International, BPC BioSed, Carolina Liquid Chemistries, Abaxis Europe, AMS Alliance, Randox Laboratories, Rayto Life and Analytical Sciences, Scil Animal Care, Crony Instruments, DiaSys Diagnostic Systems, Eurolyser Diagnostica, Gesan Production, Heska, Idexx Laboratories, LITEON IT Corporation, Shenzhen Icubio Biomedical Technology, URIT Medical Electronic.
The globalization of pet humanization, increasing financial support for the animal health field, innovative techniques and advancements for bringing testing to the point of care (POC), an increase in hospital visits from animals, and an increase in the use of POC diagnostics are the major market drivers.
The lack of awareness and the high cost associated with the product are the major market restraints.
An increase in research and investment in the development of the device are the major opportunities in the automatic veterinary biochemistry analyzer industry.